
Yahoo · 9 de sept de 2026
On September 3, a caller asked whether to rotate out of artificial intelligence stocks and add to Eli Lilly and Company (NYSE:LLY) rather than chase Johnson & J…
Cardinal Health Inc
Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company offers customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
Últimos 200 días · 12/11/25 — 09/09/26
+26.99%
Precio
$ 127.375
Var. %
+0,13%
Volumen operado
34
Precio CAH
US$ 240,04
Teórico (precio / ratio)
CAH ÷ 3
US$ 80,01
Sí, existe el CEDEAR de CAH (Cardinal Health Inc) en la Bolsa de Comercio de Buenos Aires (BYMA). Su ticker local es CAH.
El ticker del CEDEAR de Cardinal Health Inc en Argentina es CAH. La acción subyacente cotiza en NYSE con el símbolo CAH.
El CEDEAR CAH tiene un ratio de 3:1. Eso significa que 3 CEDEARs equivalen a 1 acción de CAH.
El CEDEAR CAH cotiza hoy a $ 127.375 en pesos argentinos, con una variación diaria de +0,13%.
La acción subyacente CAH (Cardinal Health Inc) cotiza a US$ 240,04 en su mercado de origen (NYSE).

Yahoo · 9 de sept de 2026
On September 3, a caller asked whether to rotate out of artificial intelligence stocks and add to Eli Lilly and Company (NYSE:LLY) rather than chase Johnson & J…

SeekingAlpha · 9 de sept de 2026
Cardinal Health, Inc. (CAH) Wells Fargo 21st Annual Healthcare Conference September 9, 2026 8:45 AM EDTCompany ParticipantsDavid Frost - Vice President of...

Yahoo · 8 de sept de 2026
In the latest trading session, Cardinal Health (CAH) closed at $240.49, marking a -2.71% move from the previous day.
Precio de cierre en pesos argentinos. Fuente: data912.
Cotización
US$ 84,40
vs teórico
+5,48%
Cotización MEP implícita
$ 1.509,18
Cotización
—
vs teórico
—
Cotización Cable implícita
—
El precio teórico del CEDEAR CAH se calcula dividiendo el precio de CAH por el ratio (3). Hoy resulta en US$ 80,01.
En BYMA podés operar CAH en pesos, CAHD en dólar MEP y CAHC en dólar cable. Cada modalidad refleja un tipo de cambio distinto.
En esta página encontrás un gráfico con el precio histórico del CEDEAR CAH en pesos argentinos, con datos de data912.

Yahoo · 8 de sept de 2026
Technology is becoming a bigger part of CAH's strategy, linking distribution, specialty services and logistics through digital workflows.

Yahoo · 8 de sept de 2026
McKesson (NYSE:MCK) discussed its planned $2.25 billion acquisition of Precision Medicine Group, first-quarter operating trends and capital-allocation prioritie…

Yahoo · 4 de sept de 2026
AbbVie's immunology pivot is offsetting Humira's decline, while Pfizer trades at half the valuation despite patent risks ahead.

Yahoo · 3 de sept de 2026
On the September 2 episode of Mad Money, Jim Cramer called Cardinal Health, Inc. (NYSE:CAH) one of his “absolute favorites” and mentioned its growing exposure t…

Yahoo · 3 de sept de 2026
Cencora raised its fiscal 2026 EPS outlook as specialty businesses fueled stronger profit growth despite mix, pricing and financing pressures.
Noticias vía Finnhub